---
title: "Vivoryon Therapeutics N.V. Provides Update on Growing Body of Evidence Validating Glutaminyl Cyclases as Promising Targets in DKD at World Congress of Nephrology | VVY Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280866041.md"
description: "Vivoryon Therapeutics N.V. Provides Update on Growing Body of Evidence Validating Glutaminyl Cyclases as Promising Targets in DKD at World Congress of Nephrology | VVY Stock News"
datetime: "2026-03-27T22:01:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280866041.md)
  - [en](https://longbridge.com/en/news/280866041.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280866041.md)
---

# Vivoryon Therapeutics N.V. Provides Update on Growing Body of Evidence Validating Glutaminyl Cyclases as Promising Targets in DKD at World Congress of Nephrology | VVY Stock News

Vivoryon Therapeutics N.V. Provides Update on Growing Body of Evidence Validating Glutaminyl Cyclases as Promising Targets in DKD at World Congress of Nephrology | VVY Stock News

### Related Stocks

- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [VVOS.US](https://longbridge.com/en/quote/VVOS.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)

## Related News & Research

- [Vivos President Brad Weeks acquires $4,600 of common shares](https://longbridge.com/en/news/293512872.md)
- [Michael C. Skaff Discloses Investment at Vivos Therapeutics with 19.9% Stake](https://longbridge.com/en/news/292818656.md)
- [Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants | VVOS Stock News](https://longbridge.com/en/news/291286468.md)
- [Vivos says study shows Vida oral appliance cuts insomnia severity in all 37 patients](https://longbridge.com/en/news/291285922.md)
- [Vivos Therapeutics Plans Rights Offering to Existing Shareholders](https://longbridge.com/en/news/289971330.md)